| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $1,101,337 ) |
| | 2025 | 2025 | APLEXIS INC | 342 BEVERLY DR | WILMETTE | IL | 60091-3011 | COOK | USA | R44HL165997 | Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis | 000 | 3 | NIH | 2/28/2025 | $1,101,337 |
|
| Issue Date FY: 2024 ( Subtotal = $1,101,336 ) |
| | 2024 | 2024 | APLEXIS INC | 342 BEVERLY DR | WILMETTE | IL | 60091-3011 | COOK | USA | R44HL165997 | Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis | 000 | 2 | NIH | 3/7/2024 | $1,101,337 |
| | 2024 | 2022 | APLEXIS INC | 342 BEVERLY DR | WILMETTE | IL | 60091-3011 | COOK | USA | R43HL165997 | Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis | 001 | 1 | NIH | 3/1/2024 | -$1 |
| | 2024 | 2022 | APLEXIS INC | 342 BEVERLY DR | WILMETTE | IL | 60091-3011 | COOK | USA | R43HL165997 | Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis | 000 | 1 | NIH | 2/23/2024 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $397,198 ) |
| | 2022 | 2022 | APLEXIS, INC. | 342 BEVERLY DR | WILMETTE | IL | 60091-3011 | COOK | USA | R43HL165997 | Developing small molecule inhibitors of Pleckstrin-2 to treat thrombosis | 000 | 1 | NIH | 9/15/2022 | $397,198 |
|
|
